GoodRx Holdings (GDRX) Accumulated Expenses (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Accumulated Expenses for 7 consecutive years, with $86.7 million as the latest value for Q4 2025.
- Quarterly Accumulated Expenses rose 4.05% to $86.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86.7 million through Dec 2025, up 4.05% year-over-year, with the annual reading at $86.7 million for FY2025, 4.05% up from the prior year.
- Accumulated Expenses hit $86.7 million in Q4 2025 for GoodRx Holdings, down from $143.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $143.4 million in Q3 2025 to a low of $9.6 million in Q1 2021.
- Historically, Accumulated Expenses has averaged $63.8 million across 5 years, with a median of $68.4 million in 2023.
- Biggest five-year swings in Accumulated Expenses: soared 273.26% in 2021 and later grew 4.05% in 2025.
- Year by year, Accumulated Expenses stood at $15.5 million in 2021, then skyrocketed by 206.74% to $47.5 million in 2022, then skyrocketed by 50.09% to $71.3 million in 2023, then increased by 16.83% to $83.3 million in 2024, then grew by 4.05% to $86.7 million in 2025.
- Business Quant data shows Accumulated Expenses for GDRX at $86.7 million in Q4 2025, $143.4 million in Q3 2025, and $95.7 million in Q2 2025.